Literature DB >> 9612366

Insulin improves contractile function during moderate ischemia in canine left ventricle.

J D Tune1, R T Mallet, H F Downey.   

Abstract

This study determined the effects of insulin on myocardial contractile function and glucose metabolism during moderate coronary hypoperfusion. Coronary perfusion pressure (CPP) was lowered from 100 to 60, 50, and 40 mmHg in the left anterior descending coronary artery of anesthetized, open-chest dogs. Regional glucose uptake (GU), lactate uptake, myocardial O2 consumption, and percent segment shortening (%SS) were measured without (n = 12) or with intravenous (4 U/min, n = 12) or intracoronary insulin (4 U/min, n = 6). Glucose metabolites were also measured in freeze-clamped biopsies of control heart (n = 6) and hearts treated with intravenous insulin (n = 6) at the completion of the protocol (40 mmHg CPP). GU increased with intravenous and intracoronary insulin (P < 0.01). In all groups, GU was unaffected by reduced CPP, although lactate uptake decreased significantly (P < 0.01). Myocardial O2 consumption fell (P < 0.05) as CPP was lowered in all groups and was not altered significantly by intravenous or intracoronary insulin treatment. Without insulin, %SS decreased 72% (P < 0.05) at 40 mmHg CPP, but in hearts treated with intravenous and intracoronary insulin, %SS was not reduced (P > 0.05). Myocardial glycogen, alanine, lactate, and pyruvate contents were not significantly different in untreated hearts and hearts treated with intravenous insulin. Thus, in moderately ischemic canine myocardium, insulin markedly improved regional contractile function and did not appreciably increase the products of anaerobic glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9612366     DOI: 10.1152/ajpheart.1998.274.5.H1574

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  The effect of insulin on the heart: Part 2: Effects on function during and post myocardial ischaemia.

Authors:  L J Klein; F C Visser
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

2.  Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized controlled trials.

Authors:  Yiyang Zhao; Yang Wu; Bo Xiang
Journal:  Pediatr Res       Date:  2018-05-24       Impact factor: 3.756

3.  Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow.

Authors:  Steven P Moberly; Zachary C Berwick; Meredith Kohr; Mark Svendsen; Kieren J Mather; Johnathan D Tune
Journal:  Exp Biol Med (Maywood)       Date:  2012-02-16

4.  Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia.

Authors:  Peipei Wang; Joshua M Tate; Steven G Lloyd
Journal:  Life Sci       Date:  2008-10-10       Impact factor: 5.037

5.  Effect of glucose-insulin-potassium infusion on oxidative stress in patients with dilated cardiomyopathy.

Authors:  Emine Diraman; Gunnur Demircan; Sabri Demircan; Mustafa Yazici; Kenan Durna; Firat Ural; Zafer Eren
Journal:  Exp Clin Cardiol       Date:  2008

6.  Insulin-dependent rescue from cardiogenic shock is not mediated by phospholamban phosphorylation.

Authors:  Naa-Adjeley Ablorh; Florentin Nitu; Kristin Engebretsen; David D Thomas; Joel S Holger
Journal:  Clin Toxicol (Phila)       Date:  2009-04       Impact factor: 4.467

7.  Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized controlled trials.

Authors:  Yiyang Zhao; Yang Wu; Bo Xiang
Journal:  Pediatr Res       Date:  2018-03-28       Impact factor: 3.756

8.  High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity.

Authors:  Christina Woodward; Ali Pourmand; Maryann Mazer-Amirshahi
Journal:  Daru       Date:  2014-04-08       Impact factor: 3.117

9.  Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.

Authors:  Melody A de Laat; Kaylynn J Gruntmeir; Christopher C Pollitt; Catherine M McGowan; Martin N Sillence; Véronique A Lacombe
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-22       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.